Aesthetic Solutions is participating in a study to assess the safety and efficacy of combining the properties of currently marketed medications in the treatment of subjects with acne vulgaris.
The duration of the study is 18 weeks and consists of a Baseline Visit, and four Follow-up Visits at Weeks 4, 8, 12, and 18. A Financial compensation of $250.00 is offered for your time.
Selection and Withdrawal of Subjects: We will evaluate all interested subjects and make our selection based on the eligibility criteria.
Exclusion Criteria: Please do not respond to this ad if you have used Accutane (isotrentinoin) in the last 12 months. Please do not respond to this ad if you have started using birth control pills in the last 12 months.
Inclusion Criteria: Outpatient, male or female subjects of any race, and at least 12 years of age may participate. Female subjects of childbearing potential must have a negative urin pregnancy test result at Baseline and practice a reliable method of contraception throughout the study.
Subjects must have moderate to severe facial acne with at least 10-15 acne lesions.
Please call Aesthetic Solutions and speak to Karlee.
Karlee will administer the complete eligibility criteria to see if you are a good candidate for study participation.
Aesthetic Solutions
Sue Ellen Cox, MD and J. Charles Finn, MD
5821 Farrington Rd. Suite 101
Chapel Hill, NC 27517